ΛΙΣΤΑ ΚΟΙΝΟΠΟΙΗΣΕΩΝ ΣΤΗ ΦΙΛΟΣΟΦΙΚΗ ΣΧΟΛΗ

Seminar on Cancer Immunobiology and Immunotherapeutics_Uoc Medical School_17/3/2025

To: "News University of Crete" <press@xxxxxxxxxxxx>

Subject: Seminar on Cancer Immunobiology and Immunotherapeutics_Uoc Medical School_17/3/2025

From: "News University of Crete" <press@xxxxxxxxxxxx>

Date: Thu, 27 Feb 2025 13:28:30 +0200

Authentication-results: mail.extra.fks.uoc.gr (amavisd-new); dkim=pass header.i=@admin.uoc.gr

Authentication-results: mx02.uoc.gr; dmarc=pass (p=none dis=none) header.from=admin.uoc.gr

Authentication-results: mx02.uoc.gr; spf=pass smtp.mailfrom=uoc.gr

Authentication-results: mx02.uoc.gr; dkim=pass (2048-bit key, unprotected) header.d=admin.uoc.gr header.i=@admin.uoc.gr header.a=rsa-sha256 header.s=201911 header.b=kdeYJZa2; dkim=pass (2048-bit key) header.d=admin.uoc.gr header.i=@admin.uoc.gr header.a=rsa-sha256 header.s=201911 header.b=SYOfkQdz

Authentication-results: hermes01; dkim=pass (2048-bit key; unprotected) header.d=admin.uoc.gr header.i=@admin.uoc.gr header.b="SYOfkQdz"; dkim-atps=neutral

Authentication-results: mx02.uoc.gr; dmarc=pass (p=none dis=none) header.from=admin.uoc.gr

Authentication-results: mx02.uoc.gr; spf=pass smtp.mailfrom=admin.uoc.gr

Delivered-to: notify@xxxxxxxxxx

Dkim-filter: OpenDKIM Filter v2.11.0 mx02.uoc.gr 4Z3TcN36htzbV

Dkim-filter: OpenDKIM Filter v2.11.0 mx02.uoc.gr 4Z3TcJ5xhhzl4d

Dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=admin.uoc.gr; s=201911; t=1740655716; bh=Qi+vSZNvzr4WrT6q2a2wENAVegeHIxba92wNnui49U4=; h=From:To:References:In-Reply-To:Subject:Date; b=kdeYJZa2vQa0cUCJLMCdpKtP9lRAomnM0diZPYfkia6phSTCmOyoZ++HtwVWxUWQk 0ovvp7ZTcthLgtrJNtemTALSgZ3Ht94/wpQT0DJVm2LtiGUR0n41c9BTpqE9aR2Saz qNLdfm4T7PKG5lc69l6h9VpU+HMIK0+/ABM4sHSickUxo3crjV6BrNM75BZB3yQvSO BbhlgbOw5o22XAN8s+6aBoSU9m9NT9kN3efhFt092GqweyjvBy36wDxaCi514IyxhG 5GC5cpbqSgER9clyzy7xHKtVvOhOfeXA0FQV7GteXuIOHanhsaDfmxYk/d7hh9plqI I8HJEYxYjqqRw==

Dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=admin.uoc.gr; s=201911; t=1740655712; bh=Qi+vSZNvzr4WrT6q2a2wENAVegeHIxba92wNnui49U4=; h=From:To:References:In-Reply-To:Subject:Date; b=SYOfkQdzt0uIHvvP132vZTtSO4yJ417JuFGod1xRL/PQHykJfHF2C6UFDJtGFyig9 lpzAK0qoKZrufczJ7lKefByLN3Fm0qBcHB4z9s9Cx4V4OsVm02q6Io5+Xm/J7YVQcX xRX9sD/vdySRpRrXg/ZDu+CKeJR81515Wbyn8BCkRCf5V4NhspIoKXDvgwDFOwEvcT 2D0whnW+OPFX2V6Niq4V0zeVzaAMppsLiHHze5vkKgtxuGhhNkX1MCFXPA0SeFK484 5GfmD4PcZHz83cgFdHPnQLTjBXB0fyF3pRowVBdjTexTRIfdUJup6alddT4dCFUpqO kkkb3kN2vTEPQ==

Dmarc-filter: OpenDMARC Filter v1.4.2 mx02.uoc.gr 4Z3TcN36htzbV

Dmarc-filter: OpenDMARC Filter v1.4.2 mx02.uoc.gr 4Z3TcJ5xhhzl4d

In-reply-to: <CANgHHc0R2H837aiejxG2JTJhJPXQeq0pYzcXG=kC090_xU2neg@mail.gmail.com>

References: <d82fce831bb63de627a187b08f1a93ef@uoc.gr> <6867b60271a479e4574df4f1dc764fbd@uoc.gr> <CANgHHc0R2H837aiejxG2JTJhJPXQeq0pYzcXG=kC090_xU2neg@mail.gmail.com>

Thread-index: AQH9RitPeJGmd9r1Yyaeg/mCRSaUngH5UOuCApZf/BOy8wnUMA==

ΘΕΜΑ: Seminar on Cancer Immunobiology and Immunotherapeutics_Uoc Medical School_17/3/2025

ΑΠΟΣΤΟΛΕΑΣ: Baritaki Stavroula <baritaks@xxxxxx>

Ιατρική Σχολή Πανεπιστημίου Κρήτης

SEMINAR

Monday, March 17th, 2025

Graduate Studies Amphitheater,

Μedical School, University of Crete

Time: 10:00am

"B cell and antibody immune responses:

their significance in the design of monoclonal antibodies for cancer therapy"

Prof. Sophia Karagiannis

Translational Cancer Immunology and Immunotherapy

King's College London

Virtual link: https://uoc-gr.zoom.us/j/89775541355?pwd=M26x9IMV2a4zw2c3r7QUaUMwdmaaiy.1

Meeting ID: 897 7554 1355
Passcode: 118085

Short Biograph: Sophia Karagiannis is a translational cancer immunologist specializing in antibody therapies for melanoma, ovarian and breast carcinomas. Gained BA and MS degrees at Rutgers University, USA, having received scholarship awards and a teaching assistantship (1987, 1991). PhD was awarded at King's College London in Biochemistry under SERC and SmithKline Beecham-funded scholarships (1995). Subsequently developed immunotherapeutic strategies for cancer and inflammatory diseases in academic and biotechnology environments in London and Cambridge as a postdoctoral associate and scientific investigator and formed a research group as a NIHR/BRC Senior Research Fellow in 2007. The Karagiannis team at King's College London is presently focused on dissecting humoral immunity in cancer and elucidating tumor-targeting and immune effector activating mechanisms of IgE and IgG antibodies.

Co-founded and co-chairs the International Task Force on AllergoOncology and has pioneered IgE therapeutics for solid tumors. Her research and development initiative on the first IgE class antibody for cancer therapy is conducted in close collaboration with clinical and academic groups at King's College London and the CR-UL Drug Development Office.

---

Stavroula Baritaki, Μ.Sc.,Ph.D.

Assοciate Professor of Experimental Oncology

Head, Experimental Oncology Research Laboratory

School of Medicine, University of Crete

P.O. Box 2208, Voutes Campus

Heraklion, Crete, 710 03 GREECE

Office: +302810394727

Email: baritaks@xxxxxx

Website: http://leo.med.uoc.gr/

ΦΙΛΟΣΟΦΙΚΗ ΣΧΟΛΗ